VRTX VERTEX PHARMACEUTICALS INC / MA: institutional ownership and insider trading
1,912 funds reported holding $135B of VERTEX PHARMACEUTICALS INC / MA in their latest 13F filings; in Q2 2026 funds net bought $4.77B, with 173 new positions and 109 funds selling out; over the last 12 months insiders bought $0 and sold $158M on the open market.
Famous investors holding VRTX
- Tweedy, Browne (Tweedy, Browne Company): $19.9M, 1.5% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $159M, 0.2% of the portfolio
- Izzy Englander (Millennium Management): $280M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $143M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $442M, 0.1% of the portfolio
- Ray Dalio (Bridgewater Associates): $5.40M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $9.04M, 0.0% of the portfolio
Largest institutional holders of VRTX
- Capital World Investors — $13.0B
- BlackRock, Inc. (BLK) — $12.0B
- VANGUARD GROUP INC — $10.9B
- Capital Research Global Investors — $9.68B
- VANGUARD CAPITAL MANAGEMENT LLC — $8.24B
- STATE STREET CORP (STT, STT-PG) — $5.90B
- Invesco Ltd. (IVZ) — $4.00B
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $3.26B
- GEODE CAPITAL MANAGEMENT, LLC — $2.98B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $2.42B
Recent VRTX insider trades
- Jul 2, 2026: McKechnie Duncan sold 1,541 shares ($800K)
- Jul 2, 2026: Tatsis Ourania sold 1,500 shares ($787K)
- Jul 1, 2026: Liu Joy sold 828 shares ($416K)
- Jun 26, 2026: Bozic Carmen sold 596 shares ($288K)
Members of Congress trading VRTX
- Aug 26, 2026: David J. Taylor sold $1.00K–$15.0K
- Jan 29, 2026: David J. Taylor sold $1.00K–$15.0K
- Aug 7, 2025: David J. Taylor bought $1.00K–$15.0K
- Jun 11, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Jun 10, 2025: Lisa C. McClain sold part of $1.00K–$15.0K
- May 12, 2025: Jefferson Shreve sold $15.0K–$50.0K
- Mar 20, 2025: Byron Donalds sold $1.00K–$15.0K
- Mar 20, 2025: Byron Donalds sold $1.00K–$15.0K
- Mar 13, 2025: Jefferson Shreve bought $15.0K–$50.0K
- Feb 24, 2025: Jefferson Shreve bought $15.0K–$50.0K
5%+ owners
- Capital World Investors: 10.1% (Schedule 13G/A, filed May 14, 2026)
- Capital Research Global Investors: 8.3% (Schedule 13G/A, filed May 14, 2026)
- Vanguard Capital Management: 7.5% (Schedule 13G, filed Apr 30, 2026)